About 20 Stevens–Johnson syndrome/toxic epidermal necrolysis cases have been reported with other inhibitors of PD-1 or its ligand [38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55]. This evidence concerns the gene PDCD1 and toxic epidermal necrolysis.